Study finds 18 percent chance Ebola will arrive in the U.S. this month
The outbreak of Ebola in West Africa has public health officials very alarmed. It is the world's largest and deadliest outbreak yet, and has infected about 3,600 people and killed at least 1,841 in three countries, according to the World Health Organization's tally. But there's a good chance the virus will spread outside of Guinea, Sierra Leone, and Liberia.
How good a chance? A study this week puts the odds that Ebola will arrive in the U.S. in late September as high as 18 percent. The study, published in PLOS Currents: Outbreaks, analyzed patterns of daily flights from the infected countries, keeping in mind how hard it will be to keep an infected person from boarding commercial airliners:
The 18 percent figure is the high end of the study's range for the U.S., but "what is happening in West Africa is going to get here," senior author Alessandro Vespignani tells NPR. "We can't escape that at this point." Vespignani isn't predicting a massive outbreak like in Africa, but "very small clusters of cases, between one and three." The odds of an Ebola panic are probably higher.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Still, the U.S. is fortunate in comparison. The chances of an Ebola carrier arriving elsewhere in Africa is much higher, and Britain's odds are as high as 25-28 percent by late September, the study found.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
How Tesla has put Elon Musk on track to be the world’s first trillionaireIn The Spotlight The package agreed by the Tesla board outlines several key milestones over a 10-year period
-
Cop30: is the UN climate summit over before it begins?Today’s Big Question Trump administration will not send any high-level representatives, while most nations failed to submit updated plans for cutting greenhouse gas emissions
-
‘The Big Crunch’: why science is divided over the future of the universeThe Explainer New study upends the prevailing theory about dark matter and says it is weakening
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
